Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 4 1

Status

Recruiting 17Completed 17Unknown 7Not yet recruiting 5Withdrawn 4Terminated 4Active not recruiting 2

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 44Colorectal Neoplasms 22Breast Neoplasms 22Stomach Neoplasms 21Neoplasms 18Esophageal Squamous Cell Carcinoma 12Neoplasm Metastasis 11Nasopharyngeal Carcinoma 11Lung Neoplasms 11Rectal Neoplasms 9Colonic Neoplasms 8Pancreatic Neoplasms 7Uterine Cervical Neoplasms 6Esophageal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Osteosarcoma 5Brain Neoplasms 5Small Cell Lung Carcinoma 4Recurrence 4Glioblastoma 4Gastrointestinal Neoplasms 4Precision Cell Immunotherapy 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Head and Neck Neoplasms 3Gastrointestinal Diseases 3Digestive System Neoplasms 3Carcinoma, Ovarian Epithelial 3

Interventions

Gemcitabine 78Fluorouracil 27Oxaliplatin 24130-nm albumin-bound paclitaxel 24Leucovorin 18Capecitabine 15Albumin-Bound Paclitaxel 15S 1 (combination) 14Taxes 12Irinotecan 11pembrolizumab 9folfirinox 9Radiosurgery 9Radiotherapy 7Drug Therapy 7Cisplatin 7irinotecan sucrosofate 6Pancreaticoduodenectomy 5Paclitaxel 5Injections 5Docetaxel 5Blood Specimen Collection 5apatinib 4Radiofrequency Ablation 4Radiation 4Biopsy 4tislelizumab 3rubitecan 3nimotuzumab 3camrelizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × Pancreatic Neoplasms × Drug Therapy × Clear all
NCT04638751 2024-04-05

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Persephone Biosciences

Unknown
5,000 enrolled
BreastGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT05399394 2022-06-01

FOLRT

Campus Bio-Medico University

Phase 2 Unknown
50 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01676259 2021-07-02

PROTACT

Silenseed Ltd

Phase 2 Unknown
80 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT03460925 2018-05-30

IRENE

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase NA Unknown
14 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03401827 2018-02-12

The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer

Seoul National University Hospital

Phase 4 Unknown
40 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02754180 2016-04-28

Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes

Peking Union Medical College Hospital

Phase 2 Unknown
110 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00323583 2007-05-08

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

Seattle Cancer Treatment and Wellness Center

Phase 2 Unknown
80 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡